PubMed · 13748708
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
G SCHUBERT. 1961. [Erythrocytes below the "boiling point"].. https://pubmed.ncbi.nlm.nih.gov/13748708/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
BACKGROUND: A minority of blood donors are Rh(D)-negative, and Rh(D)-negative red blood cell (RBC) products are often overutilized. As such, Rh(D)-negative RBCs may be difficult to maintain in blood bank inventory. STUDY DESIGN AND METHODS: We changed our blood bank laboratory policy to approve non-alloimmunized Rh(D)-negative patients to receive Rh(D)-positive RBCs for routine transfusion under defined criteria. Those criteria included Rh(D)-negative males (all ages) and females (aged >50 years) who were designated as do not resuscitate (DNR), either with or without intubation, in the electronic medical record. RESULTS: From August 15, 2024 through August 15, 2025, a total of 204 Rh(D)-negative patients met the above criteria and were approved to receive routine Rh(D)-positive RBC transfusions. Within that group, 23 patients received Rh(D)-positive RBCs. The remaining patients either did not require transfusion or were issued Rh(D)-negative RBC units. Since implementing this practice, a total of 68 Rh(D)-negative units were conserved during this time frame. Notably, 28 of the 68 units (41%) were type O, Rh(D)-negative. DISCUSSION: Rh(D)-positive RBCs can be routinely given to non-alloimmunized Rh(D)-negative patients who are not at risk for developing hemolytic disease of the fetus and newborn (HDFN). By creating clear guidelines for the routine administration of Rh(D)-positive RBCs to patients who are not at risk for HDFN, the inventory of Rh(D)-negative RBC units can be directed to those patients who would most benefit from this limited resource.
A highly versatile setup, which introduces an optical gradient trap into a Raman spectrometer, is presented. The particular configuration, which consists of two lasers, makes trapping independent from the Raman excitation laser and allows a separate adjustment of the trapping and excitation wavelengths. Thus, the excitation wavelength can be chosen according to the needs of the application. We describe the successful application of an optical gradient trap on transparent as well as on reflective, metal-coated microparticles. Raman spectra were recorded from optically trapped polystyrene beads and from single biological cells (e.g., erythrocytes, yeast cells). Also, metal-coated microparticles were trapped and used as surface enhanced Raman spectroscopy (SERS) substrates for tests on yeast cells. Furthermore, the optical gradient trap was combined with a SERS fiber probe. Raman spectra were recorded from trapped red blood cells using the SERS fiber probe for excitation.
This study was designed to evaluate changes in erythrocyte contents during endurance moderate intensity exercise, a model of physiological oxidative stress. 16 endurance-trained subjects cycled 2 h at 55% of maximal aerobic capacity and blood was collected every 15 min. Transmission FT-IR spectrometry was used to analyze separately plasma and erythrocyte content changes during oxidative stress. Erythrocyte FT-IR spectra were corrected for hemoconcentration (Hc) before spectral areas integration of main IR absorbances belonging to phospholipids [nu(as)(CH(3)), [nu(as)(CH(2)), and nu(P=O)], proteins [nu(C=O) and delta(N-H)], and lactate [nu(C-O)] were used to determine erythrocyte content changes. Changes in nu(as)(CH(2)) and nu(P=O) absorbances while nu(as)(CH(3)) remained stable showed the magnitude of free radical attacks on phospholipids bilayer. Decrease in nu(C=O) and delta(N-H) absorbances while plasma and intracellular lactate, O(2) consumption, and Hc rose were linked to hemoglobin, and possibly spectrin, denaturation. Finally, the synergistic changes found between physiological, plasmatic and erythrocyte parameters showed that FT-IR spectrometry was a sufficiently accurate and sensitive method to determine acute changes in erythrocytes during moderate, physiological, oxidative stress.